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Background: Gastric polyps (GP) are characterised by luminal overgrowths projecting above the plane of the mucosal
surface that can be classified as non-neoplastic and neoplastic lesions. In humans, recent studies have drawn attention
to the malignant potential of some of these lesions. However, gastric polyps are uncommon lesions in dogs.
Findings: In this study, the presence of Helicobacter spp., the cellular proliferative activity, potential phenotypic
alterations, COX-2 and p53 expression in canine spontaneous gastric polyps were investigated. The expression of these
molecules was also studied in normal canine gastric mucosa in order to gain further knowledge of the significance of
their loss or overexpression in gastric lesions.
Conclusions: The normal expression of almost all the factors evaluated, along with the reduced proliferative activity is
strongly suggestive that, in dogs, spontaneous gastric polyps are not only a rare finding but also of benign nature.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
13000_2014_166
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Gastric polyps (GPs) are considered a heterogeneous
entity broadly defined as luminal lesions projecting
above the plane of the mucosal surface that can be
biologically classified as non-neoplastic and neoplastic
lesions. In humans, further classification relies on the
evaluation of the histogenesis and neoplastic potential of
these lesions [1]. Accordingly, among the non-neoplastic
epithelial gastric polyps, three subtypes are recognized:
fundic gland polyps; hyperplastic polyps (and variants)
and neuroendocrine tumours (NET).
Fundic gland polyps represent the most common type
and they are histologically characterized by cistically
dilated fundic-type glands lined by flattened parietal cells
with a degree of architectural distortion. The surface
comprises foveolar type epithelium, which may appear* Correspondence: fgartner@ipatimup.pt
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unless otherwise stated.atrophic [1]. The hyperplastic polyps are typically observed
in the antrum and histologically consist in hyperplastic,
elongated and branching foveolae set in an abundant
oedematous and inflamed stroma. Cystic dilation of the
pits is almost invariable present in the deeper portions and
surface is lined by a single-layer of foveolar-type epithelium
[1]. Hyperplastic polyps occur against a background
of gastritis and its development is a consequence of an
exaggerated mucosal response to injury. They are related
to Helicobacter pylori (H. pylori) infection and some
authors concluded that H. pylori eradication cause complete
regression or significant decrease in its size. It is important
to be aware that foci of dysplasia or intramucosal carcinoma
can be encountered in these lesions [1,2]. Lastly, NET or
the so called “carcinoid” tumours are histologically
composed of nests, cords, tubules, and clusters of cells
that predominantly interposed between the foveolar basis,
without disturbing the overall polyp architecture [3].
Contrary to the documented progression in human
colorectal cancer, the association of GPs with the
development of gastric cancer is still not fully established
but studies emphasize the malignant potential of thesel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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http://www.diagnosticpathology.org/content/9/1/166lesions. GPs are uncommon in dogs and are occasional
incidental findings during endoscopy or postmortem
examinations [4]. Sporadic canine GPs are rare and the
relevant literature is scarce. Only recently Taulescu et al.
[5] described the histopathological features of 15 lesions.
Regarding non-neoplastic polypoid growths, the World
Health Organization (WHO) for the classification of
tumors in domestic animals presents a simplest scheme
where only two entities are recognized: the hyperplastic
(regenerative) and the inflammatory (benign lymphoid)
polyps. The former are histologically identical to the
human homonymous lesion and the gold standard of the
later is the presence of a normal epithelium covering
a granulation tissue core infiltrated by a variety of inflam-
matory cells, sometimes accompanied by lymphoid
aggregates with prominent germinal centers [4].
Several studies trying to involve some markers for
malignant transformation in human gastric hyperplastic
polyps were performed however, a specific molecule that
could identify which polyp will undergo malignant trans-
formation has not yet been found. In the dog, not much is
known with this regard.
Cyclooxygenase (COX) is the enzyme that allows
synthesis of prostaglandins and other eicosanoids from
arachidonic acid. COX-2 isoform plays an important role
in gastric cancer development through apoptosis inhib-
ition and increased cell proliferation. Although few studies
reported the increased expression of COX-2 in canine
cancers no data is available regarding COX-2 expression
in canine gastric tissues [6].
Cellular kinetics is thought to participate in the
progression towards gastric cancer. Ki-67 antibody is
used to measure the proliferation index of a particular
tissue assuming that higher Ki-67 reveals tumour cell
activity and predicts the further behaviour of a specific
pathology [7].
Malignant transformation of human hyperplastic GPs
is associated with dysplasia, with p53 playing a crucial
role in the process [8]. Overexpression of mutated p53
has been correlated with pathological parameters of
tumour aggressiveness and poor prognosis in human
gastric carcinoma [9].
According to Correa’s model [10], human gastric
cancer develops in a multistep process from chronic
active gastritis to intestinal metaplasia (IM), dysplasia,
and finally, gastric cancer. IM is regarded as precursor
lesion, consisting of the transdifferentiation of gastric
mucosa to an intestinal phenotype, characterised by the
aberrant expression of the homeobox transcription factor
CDX2 [11]. Expression of CDX2 in canine GPs has never
been characterised.
As uncommon lesions, the molecular properties and
neoplastic potential of canine GPs remains an area of
interest. The purpose of this study is to describe somemolecular features of these lesions in order to better
understand their biological behaviour. Additionally, the
expression of these molecules in normal gastric mucosa
(NGM) was investigated to evaluate the significance of
their loss or overexpression in gastric lesions.
Animals & methods
Four normal canine antral gastric mucosa specimens
and nine canine antral GPs (Figure 1A), received between
2007 and 2013, were selected from the archives of the
Laboratory of Veterinary Pathology, ICBAS-UP (Portugal)
and Pathology Department of FVM, Cluj-Napoca (Romania).
Tissues were fixed in 10% buffered formalin and paraffin-
embedded. Serial consecutive sections 3 μm-thick were
made, one for routine histological diagnosis and the others
for immunohistochemical studies.
Sections were independently examined by three patholo-
gists. Normal tissues were considered as such according to
Prachasilpchain et al. [10] and were negative for the pres-
ence of Helicobacter spp. (confirmed by modified Giemsa
stain and anti-H. pylori immunohistochemistry). GPs were
classified according to WHO classification for domestic
animals diagnostic criteria [3].
For the immunohistochemical study, a panel of anti-
bodies specific for several antigens was applied (Table 1).
Novolink Max-Polymer detection system (Novocastra)
was used according to the manufacturer’s instructions.
Detection of Helicobacter spp. was rated as: negative,
no organisms, or positive, presence of Helicobacter spp.
Bacterial density colonization was quantified: +, few
(<10/400×); ++, moderate (10-50/400×) and +++, large
number of organisms (>50/400×). Bacteria location was
recorded: 0 = absent; 1 = mucosal surface and gastric
pits; 2 = 1 + lumen of gastric glands (400×) [12]. COX-2
immunoexpression was scored for the percentage of
labelled cells (<25%; 25-50%; 51-75%; >75%) and labelling
intensity (0, negative; +, weak; ++, moderate; +++, strong).
The Ki-67 labelling index was defined as percentage of
positive nuclei determined by counting at least 1000
nuclei in the selected fields (×400) [8]. Additionally,
immunoreactivity was assessed considering the gastric
glands divided in three zones: zone 1 (gastric pit); zone 2
(isthmus/proliferative zone) and zone 3 (gland base) [13].
p53 and CDX2 immunoreactivity were defined as positive
when distinct nuclear staining was recognised in at least
10% of the cells [8,14].
Findings
The available clinical data, histological classification of
the lesions and main immunohistochemical results,
considering the criteria proposed for each antibody,
are summarised in Table 2.
Of nine GP lesions, seven were classified as hyperplas-
tic polyps (Figure 1B) and two as inflammatory polyps
Figure 1 Morphological and immunohistochemical features of the canine gastric polyps. (A) Gross aspect; (B) Hyperplastic polyp; (C)
Inflammatory polyp; (D) (E) H. pylori immunoexpression. (F) COX-2 immunoexpression; (G) Ki-67 immunoexpression; (H) p53 immunoexpression. Inset:
intratubular seminoma (+control) (I) CDX2 immunoexpression. Inset: normal intestine (+control). Morphological and immunohistochemical features of
the canine gastric polyps. (A) Gross aspect of the pyloric gastric mucosa showing a solitary polyp (delimited area) (case 9); (B) and (C) Microscopic
examination of haematoxylin and eosin-stained slides revealing a hyperplastic polyp (case 4) and an inflammatory polyp (case 8). Bar = 500 μm and
100 μm, respectively. (D) Photomicrograph demonstrating the positive H. pylori expression in a hyperplastic polyp (case 2). Bar = 200 μm. (E) Detail of
the previous case highlighting the large amount of Helicobacter spp. organisms inside the gastric glands. Bar = 10 μm. (F) Photomicrograph revealing
strong and diffuse COX-2 expression into branched foveolar epithelium of the hyperplastic polyp (case 1). Bar = 200 μm. Inset presenting a detail of the
COX-2 expression into foveolar epithelium; (G) Immunostaining of Ki-67 in the hyperplastic epithelium (case 3: 32.1%). Bar = 200 μm. Inset showing
the detail of KI-67 expression in the isthmus and in the glands base. (H) Photomicrograph revealing a negative immunohistochemical reactivity of p53 in
the hyperplastic polyp (case 2). Bar = 200 μm. Tissue from canine intratubular seminoma has been used as positive control for p53 (inset). (I) Negative
CDX2 expression in the hyperplastic polyp (case 1). Bar = 200 μm. Tissue from canine normal intestine has been used as positive control for CDX2 (inset).
Immunoperoxidase-diaminobenzidine stain with Mayer’s haematoxylin counterstain (D-I).
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GPs revealed Helicobacter spp. organisms (Figure 1D),
preferentially located in the lumen of the gastric glands
(Figure 1E) (Table 2).
Differences on COX-2 immunoexpression between NGM
and GPs were minimal (Table 2). Both groups presentedstrong COX-2 expression in more than 75% of gastric
superficial epithelium. Deeply, the gastric glands of NGM
showed a weak to moderate COX-2 expression, while the
glands of GPs showed strong COX-2 expression (Figure 1F).
Nevertheless, GPs presented diffuse COX-2 cytoplasm
accumulation in epithelial cells.
Table 1 Antibodies used for canine gastric tissues immunohistochemistry
Marker Clone Supplier Dilution Antigen unmasking Incubation period Positive control
H. pylori Polyclonal Zytomed, Deutschland 1:200 CB/PC ON Human gastric mucosa with H. pylori
COX-2 SP21 NeoMarkers, USA 1:75 CB/PC ON Canine mammary tumour
p53 Anti-p53 Novocastra, UK 1:400 CB/PC ON Canine intratubular seminoma
CDX2 AMT28 Novocastra, UK 1:300 CB/PC ON Canine normal intestine
KI-67 MIB-1 Dako, Denmark 1:50 CB/PC ON Canine high grade lymphoma
CB citrate buffer; PC pressure cooker.
ON overnight.
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of 24,8%) than NGM (mean value of 20,0%). Ki-67 signal
was detected only in the proliferative compartment of
NGM whereas in the GPs, this labelling often reached
zone 3 (Figure 1G).
Both p53 and CDX2 immunodetection was entirely
negative in all cases of canine NGM and GPs (Figure 1H
and I).
Discussion & conclusion
Studies regarding COX-2 in human NGM reported
lack [15,16], weak [17] or generalised expression [18].
These discrepancies are perhaps related to the
primary antibody (monoclonal or polyclonal) and to the
scoring system adopted for immunoreactivity evaluation.
The consistent expression of COX-2 in NGM could
be explained by two hypotheses: (1) COX-2 is constitu-
tively expressed in canine gastric mucosa; or (2) recent








1 Rottweiler M/12 Hyperplastic polyp ++
2 Irish Setter F/12 Hyperplastic polyp ++
3 Poodle F/12 Hyperplastic polyp ++
4 Argentine Mastiff F/9 Hyperplastic polyp ++
5 Rottweiler F/14 Hyperplastic polyp +2
6 Mixed breed F/16 Hyperplastic polyp ++
7 Poodle M/13 Inflammatory polyp ++
8 German Shepherd M/9 Inflammatory polyp ++
9 Boxer M/10 Hyperplastic polyp +1
10 Mixed breed M/2 NGM 0
11 Poodle cross F/15 NGM 0
12 Boxer M/4 NGM 0
13 Mixed breed M/8 NGM 0
M male, F female.
COX-2: SE, surface epithelium; DG, deeper glands. >75% of immunopositive cells, +
Helicobacter spp.: + few; ++ moderate number; +++ large number of organisms. Th
2 = 1+ lumen of the gastric glands; KI-67: zone 2, isthmus and zone 3, gland base; pin human gastric mucosa and McCarthy et al. [19]
concluded that COX-2 expression in antral mucosa
was reduced but not eliminated in the epithelium
after successful eradication of H. pylori. Sung et al.
[15] also showed that though eradication of H. pylori,
there was only a modest reduction of COX-2 in the
gastric epithelium, although COX-2 expression in the
lamina propria was markedly reduced. Despite these
dogs being currently negative for Helicobacter spp., it
is not possible to rule out a previous infection by
these organisms that could justify the persistent
expression of COX-2.
The overexpression of COX-2 in the deeper glands of
GPs may be explained by the presence of varying
amount of Helicobacter organisms in this gastric com-
partment which, similarly to what happens in humans
with H. pylori, may lead to an increased expression of
this enzyme through the production of proinflammatory







+2 >75%/+++ >75%/ +++ 36,12,3 - -
+2 >75%/+++ >75%/+++ 31,42,3 - -
+2 >75%/ +++ >75%/+++ 32,12,3 - -
2 >75%/+++ >75%/ +++ 28,92,3 - -
>75%/+++ >75%/+++ 30,92,3 - -
2 >75%/+++ >75%/+++ 16,72,3 - -
2 >75%/+++ >75%/+++ 31,52,3 - -
2 >75%/+++ >75%/+++ 10,82 - -
>75%/+++ >75%/+++ 4,62 - -
>75%/+++ >75%/+ 18,32 - -
>75%/+++ >75%/++ 23,62 - -
>75%/+++ >75%/+ 15,62 - -
>75%/+++ >75%/++ 22,82 - -
weak, ++ moderate, +++ strong intensity.
e bacteria location 0, absent; 1 = on mucosal surface and within gastric pits;
53 and CDX2: −, negative.
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gastric mucosa, thus its onset is necessarily related to
an increase in cell turnover and mitotic activity. Yao et al.
reported a proliferative index of 22.2% in human
hyperplastic GPs. The slightly difference in the percentages
obtained in both studies may be related to the species
in question (human vs. dog) and/or with sample size
(22 vs. 9 cases). Additionally, increased proliferation
of gastric mucosa was associated with H. pylori [20]
since the infection briefly increases apoptosis of
surface and proliferative cells and then expands the
proliferative zone to deeper in the gland, presumably
as a compensatory response [21].
The proliferative zone in the antral stomach is in the
lower third of the typical glands units [21], close to the
base of the gastric pits, constituting the site of cellular
renewal. This very short area, with scant or no mitoses, is
almost unidentifiable in inactive gastric mucosa. In human
NGM, Ki-67 signal is present only in the proliferative
compartment [13] as such in our study (Table 2). However,
in the GPs, this labelling often reached zone 3 (Figure 1G),
presumably because in the isthmus there are cells that
constantly regenerate others that migrate bidirectionally,
up to the mucosal surface and down to the gland base, as
they differentiate into mature cells [21].
Carrasco et al. [22] described p53-positive staining in
approximately 94.1% of canine gastric carcinomas. Our
results reinforce previous human studies in which p53
was only recognised in (pre)neoplastic components [9]
rather than non-tumoral gastric mucosa [18] or GPs [8].
Furthermore, Guo et al. [2] found co-expression of both
CA19-9 and p53 confined to small areas of atypical
epithelial cells, estimated as adenocarcinoma, present
in a human hyperplastic foveolar polyp. Additionally,
the KI-67 index was higher in these malignant foci
when compared with the surrounded gastric mucosa.
Doster et al. [23] described CDX2 expression within
foci of metaplastic change, namely goblet cells, present
in all the cases of canine gastric adenocarcinomas
included in their study. IM is an unusual phenomenon
in the dog and up to date there is no description con-
cerning its spontaneous occurrence. In humans, IM is
usually induced by continuous irritation of the gastric
mucosa and H. pylori infection remains an important
triggering factor. The molecular pathways involved in
canine regulation and function of CDX2 are unknown.
However, since the expression of the same transcription
factor is associated with the maintenance/development
of the intestinal phenotype in both humans and dogs,
the hypothesis that CDX2 is similarly regulated in both
species is plausible (data not published).
Helicobacter spp. present in cases of canine GPs may
develop different strategies of colonization, infection and
pathogenicity from those practised by H. pylori in humans,eventually justifying the rarity of IM in the stomach of the
dog. Therefore, the pathways responsible for the induction
of CDX2 expression in dogs may differ from those already
described in humans. Further studies are needed to
confirm this hypothesis.
Although certain pathological features of polyps cor-
relate with the risk of developing cancer in humans, in
dogs it’s still not possible to determine which lesions will
progress to cancer. In conclusion, the present study
suggests that canine sporadic GPs are a rare finding
and of benign nature.
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